DSIP: Evidence, Safety, Dosing and Access Questions

DSIP, also called delta sleep-inducing peptide or emideltide, is a nonapeptide studied mainly for sleep and neuroendocrine effects. Human studies exist, including randomized trials, but the evidence is older, mixed, and not enough to prove broad clinical benefit or safety. Chia does not offer DSIP treatment 1 4 9.

What it is

DSIP stands for delta sleep-inducing peptide. It is also called emideltide and is described in the human literature as a peptide studied in sleep, endocrine, and anesthesia-related settings 1 4 11.

Names: DSIP, delta sleep-inducing peptide, and emideltide

The names DSIP and delta sleep-inducing peptide appear across older human sleep studies, including research in chronic insomnia and 24-hour sleep-wake behavior 2 3 4. The name emideltide is often used when people discuss the same peptide in peptide-access or regulatory contexts, but this section does not make a legal-status claim.

Peptide class and original discovery context

DSIP is commonly described as a nonapeptide, which means a peptide made of 9 amino acids. In the retrieved human literature, it was studied most often for sleep behavior and related neuroendocrine signals, not as a broad longevity treatment 3 5 8.

What DSIP is commonly claimed to do versus what has been studied

Online, DSIP is often discussed for sleep, stress, recovery, pain, or hormone balance. The PubMed records provided here support a narrower statement: human studies from 1981 through 2009 evaluated sleep, sleep-wake behavior, selected hormones, diabetic retinopathy, and anesthesia-related measures 3 7 10 11.

Mechanism of action

The honest answer is that DSIP’s mechanism in humans is not settled. Human studies show that researchers measured sleep behavior and hormone signals after DSIP exposure, but those studies do not establish one clear receptor pathway or one proven clinical mechanism 3 5 9.

Sleep-wake regulation

Delta sleep-inducing peptide has been studied in chronic insomnia and severe chronic insomnia, including a double-blind study and a 24-hour sleep-wake behavior study 3 4. That supports saying DSIP has been investigated for sleep, but it does not prove that DSIP is a reliable sleep treatment for patients.

Neuroendocrine signaling

Several human studies tested DSIP against hormone signals. One study reported that DSIP did not affect CRH- and meal-induced ACTH and cortisol secretion, another studied arginine-vasopressin and ACTH in normal men, and another reported no influence on growth hormone and prolactin secretion in normal women 5 8 9.

Anesthesia-related measures

DSIP was also studied as an adjunct to isoflurane anesthesia, with outcomes that included bispectral index, electroencephalogram, and heart rate variability 11. That is a narrow research setting and should not be stretched into a general claim about sleep quality, sedation, or safety outside that setting.

Evidence

DSIP has an assigned evidence grade of A because the retrieved literature includes at least two human randomized controlled trials, including a double-blind chronic insomnia study, a hormone-response study, and an anesthesia-adjunct study 4 9 11. This is a grade for quantity and design, not a treatment recommendation.

What human research shows

The sleep literature includes trials in insomnia and chronic insomnia, including short-term administration, 24-hour sleep-wake behavior, and a double-blind study 2 3 4 7. These records show DSIP was studied in humans, but the titles and citation records alone do not support a precise benefit size or a reliable patient timeline.

What endocrine studies show

The endocrine records are mixed and narrow. DSIP did not affect CRH- and meal-induced ACTH and cortisol secretion in one clinical trial, did not influence growth hormone and prolactin secretion in normal women in another, and had different effects on arginine-vasopressin and ACTH secretion in normal men in a randomized trial 5 8 9.

Why older small studies still require caution

Much of the human DSIP literature in this evidence set was published between 1981 and 1995, with one anesthesia-adjunct randomized trial published in 2009 4 6 11. Older trials can be useful, but they often leave unanswered questions about modern outcome measures, longer follow-up, diverse patient groups, and real-world safety.

What studies exist

This table is retrieved from PubMed and ClinicalTrials.gov rather than assembled by hand, so it shows what is indexed — including the absences. Last retrieved 2026-09-08.

Reported dosing ranges

This page does not provide individualized DSIP dosing instructions. The PubMed citation records provided for this review identify human DSIP studies, but they do not provide enough dosing-detail text here to quote a study dosing range without risking inaccuracy 2 4 7.

For dose questions, the safer standard is source-specific: use a dose only when it is stated in the full study or in a clinician-reviewed prescription plan. For a deeper education-only look, see our guides to DSIP peptide dosage, DSIP dosing charts, and what a DSIP dosage protocol can and cannot tell you.

Legal status

This section is generated from a dated log of federal actions rather than written by hand, and it is re-checked daily against the Federal Register and FDA sources. Last checked 2026-09-08. See the full legal-status tracker for every compound we follow.

Safety

DSIP safety is not well defined from this source set. Human studies measured sleep behavior, endocrine endpoints, and anesthesia-related measures, but the provided records do not establish long-term safety, rare adverse effects, or safety in pregnancy, breastfeeding, older adults, or people with complex illness 3 5 11.

Known and unknown adverse effects

The retrieved DSIP records include clinical trials and randomized trials, which means people were studied under research conditions 1 4 9. However, the citation records do not provide a full adverse-event table, so it would be inaccurate to claim that DSIP has a complete or reassuring side-effect profile from these sources alone.

Sleep-related safety concerns

Because DSIP has been studied in insomnia and sleep-wake behavior, any possible sleep or alertness effects should be discussed with a clinician, especially if someone drives, operates equipment, uses alcohol, or takes sedating medications 2 3 4. The studies support that sleep was studied; they do not prove safe use in daily life.

Endocrine and anesthesia-related concerns

DSIP research included ACTH, cortisol, arginine-vasopressin, growth hormone, prolactin, bispectral index, electroencephalogram, and heart rate variability 5 8 9 11. That makes endocrine conditions, anesthesia plans, and heart-rhythm concerns reasonable topics to raise with a clinician before considering any sleep or peptide intervention.

Supply risks

A major safety issue with any peptide obtained outside medical care is not just the molecule; it is the source. Products sold as “research use only” are not medical care and may raise concerns about sterility, identity, impurity, storage, and lack of adverse-event support.

Interactions

No dedicated DSIP drug-interaction studies are identified in the provided PubMed record list. That is not the same as proof of no interactions; it means interaction risk is not well mapped in the retrieved human literature 2 5 11.

Sedatives, sleep medications, and alcohol

Because DSIP was studied in insomnia and sleep-wake behavior, sedatives, sleep medications, alcohol, cannabis, antihistamines, and other central nervous system depressants are important discussion points for a clinician 3 4. The records do not provide enough information to say which combinations are safe.

Hormone-related conditions and medications

Because DSIP has been studied with ACTH, cortisol, arginine-vasopressin, growth hormone, and prolactin endpoints, people with endocrine conditions or hormone-related treatment should not treat the peptide as neutral or well understood 5 8 9. A clinician can decide which risks are relevant to the person’s history.

Pregnancy, breastfeeding, chronic illness, and complex medication lists

The provided DSIP records do not establish safety in pregnancy, breastfeeding, major chronic illness, or complex medication lists. In those settings, the absence of clear interaction data should be treated as uncertainty, not reassurance 4 5 11.

How to obtain it legally

The safe process for any peptide question starts with a licensed clinician, not a checkout page. A clinician can review the reason you are asking, current medications, sleep history, labs when relevant, and whether a prescription treatment is appropriate; a prescription requires medical evaluation and is never guaranteed.

Chia does not offer DSIP. We publish education on DSIP because patients ask about it, and because a clear review is safer than marketing claims; for background, see our guides on what DSIP is and whether you can buy DSIP peptide online.

If a peptide is prescribed after a clinical evaluation, the dispensing source matters. A state-licensed pharmacy has standards for dispensing, labeling, records, and patient support; a research-chemical vendor is not a substitute for clinician evaluation, prescription oversight, or pharmacy dispensing.

At Chia, our offered treatments are reviewed 100% online by licensed US providers and, when prescribed, are compounded by state-licensed US 503A pharmacies and shipped to the patient’s door. Chia offers treatments such as sermorelin, NAD+, and GHK-Cu, but not DSIP; compounded medications are not FDA-approved.

• Ask who reviews your medical history and whether that person is licensed in the United States.
• Ask what pharmacy dispenses the medication and whether it is state-licensed.
• Ask how identity, potency, sterility, storage, and shipping are handled.
• Ask how side effects are reported and who responds if something feels wrong.
• Avoid treating a “research use only” label as patient safety information; it is not medical care. For a broader safety checklist, read our guide to finding a legitimate peptide source.

Keep reading

Peptides

DSIP Peptide Dosage Protocol: What Research Shows and What It Does Not

Peptides

DSIP Peptide Dosage: A Patient Guide to Delta Sleep-Inducing Peptide

Peptides

Can You Buy DSIP Peptide Online? What to Know Before Ordering